Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients

Overview of attention for article published in BMC Cancer, July 2021

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,163 followers.

Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients https://t.co/Cv4RAYLjcb

New article: Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients https://t.co/dB3SRXOuOl #livercancer #oncology https://t.co/1sHtHvyHd8

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.